Linked e-resources
Details
Table of Contents
Chapter 1. The Science of COVID-19 Disease
Chapter 2. Cutaneous Manifestations of COVID-19
Chapter 3. Cutaneous Reactions to COVID-19 mRNA Vaccines
Chapter 4. Cutaneous Reactions to non mRNA COVID-19 vaccines
Chapter 5. Evaluation of the Patient With a Coronavirus Disease (COVID-19) Vaccine Cutaneous Reaction
Chapter 6. Personal Protective Equipment (PPE) related Occupational Dermatoses during COVID 19
Chapter 7. COVID-19 OUTBREAK RESPONSE IN DERMATOLOGY
Chapter 8. Leveraging on teledermatology in the COVID-19 pandemic
Chapter 9. COVID-19 Dermatology Registries and the Impact of COVID-19 on Dermatology Research
Chapter 10. Impact of COVID-19 on dermatology medical education
Chapter 11. Management of immunosuppressed dermatology patients during COVID-19
Chapter 12. Therapeutic considerations of COVID-19 on aesthetic dermatology, dermatosurgery and skin cancer
Chapter 13. Psychological aspects, sychodermatology and vaccine hesitancy during the COVID-19 pandemic
Chapter 14. Oral COVID-19 Antiviral Agents in Dermatology Outpatient Treatment
Chapter 15. The Economic Impact of COVID-19 on Dermatology .
Chapter 2. Cutaneous Manifestations of COVID-19
Chapter 3. Cutaneous Reactions to COVID-19 mRNA Vaccines
Chapter 4. Cutaneous Reactions to non mRNA COVID-19 vaccines
Chapter 5. Evaluation of the Patient With a Coronavirus Disease (COVID-19) Vaccine Cutaneous Reaction
Chapter 6. Personal Protective Equipment (PPE) related Occupational Dermatoses during COVID 19
Chapter 7. COVID-19 OUTBREAK RESPONSE IN DERMATOLOGY
Chapter 8. Leveraging on teledermatology in the COVID-19 pandemic
Chapter 9. COVID-19 Dermatology Registries and the Impact of COVID-19 on Dermatology Research
Chapter 10. Impact of COVID-19 on dermatology medical education
Chapter 11. Management of immunosuppressed dermatology patients during COVID-19
Chapter 12. Therapeutic considerations of COVID-19 on aesthetic dermatology, dermatosurgery and skin cancer
Chapter 13. Psychological aspects, sychodermatology and vaccine hesitancy during the COVID-19 pandemic
Chapter 14. Oral COVID-19 Antiviral Agents in Dermatology Outpatient Treatment
Chapter 15. The Economic Impact of COVID-19 on Dermatology .